Live feed07:00:00·5mPRReleasevia QuantisnowCan-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027ByQuantisnow·Wall Street's wire, on your screen.CANF· Can-Fite Biopharma LtdHealth Care
